Association between pharmacokinetics of adalimumab and disease outcome in Japanese patients with biologics naive Crohn's disease: a subanalysis of DIAMOND trial

被引：0

作者：

Motoya, S. ^{[1
]}

Nakase, H. ^{[2
]}

Matsumoto, T. ^{[3
]}

Watanabe, K. ^{[4
]}

Hisamatsu, T. ^{[5
]}

Yoshimura, N. ^{[6
]}

Ishida, T. ^{[7
]}

Kato, S. ^{[8
]}

Nakagawa, T. ^{[9
]}

Nagahori, M. ^{[10
]}

Esaki, M. ^{[11
]}

Matsui, T. ^{[12
]}

Naito, Y. ^{[13
]}

Kanai, T. ^{[14
]}

Suzuki, Y. ^{[15
]}

Nojima, M. ^{[16
]}

Watanabe, M. ^{[10
]}

Hibi, T. ^{[17
]}

机构：

[1] Sapporo Kosei Gen Hosp, Ctr Inflammatory Bowel Dis, Sapporo, Hokkaido, Japan

[2] Sapporo Med Univ, Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan

[3] Iwate Med Univ, Div Gastroenterol, Dept Med, Morioka, Iwate, Japan

[4] Osaka City Gen Hosp, Div Gastroenterol, Osaka, Japan

[5] Kyorin Univ, Sch Med, Dept Internal Med, Tokyo, Japan

[6] Tokyo Yamate Med Ctr, Dept Med, Div Gastroenterol, Tokyo, Japan

[7] Oita Red Cross Hosp, Dept Gastroenterol, Oita, Japan

[8] Saitama Med Univ, Saitama Med Ctr, Dept Gastroenterol & Hepatol, Kawagoe, Saitama, Japan

[9] Chiba Univ, Dept Gastroenterol & Nephrol, Sch Med, Chiba, Japan

[10] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan

[11] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Fukuoka, Japan

[12] Fukuoka Univ, Dept Gastroenterol, Chikushi Hosp, Chikushino, Japan

[13] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan

[14] Keio Univ, Dept Internal Med, Sch Med, Tokyo, Japan

[15] Toho Univ, Dept Internal Med, Sakura Med Ctr, Sakura, Japan

[16] Univ Tokyo, Ctr Translat Res, Inst Med Sci Hosp, Tokyo, Japan

[17] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Tokyo, Japan

来源：

JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P523

引用

页码：S345 / S346

页数：2

共 50 条

[1] ASSOCIATION BETWEEN PHARMACOKINETICS OF ADALIMUMAB AND DISEASE OUTCOME IN JAPANESE PATIENTS WITH BIOLOGICS NAIVE CROHN'S DISEASE: A SUBANALYSIS OF DIAMOND STUDY
Nakase, Hiroshi
Motoya, Satoshi
Matsumoto, Takayuki
Watanabe, Kenji
Hisamatsu, Tadakazu
Yoshimura, Naoki
Ishida, Tetsuya
Kato, Shingo
Nakagawa, Tomoo
Esaki, Motohiro
Nagahori, Masakazu
Matsui, Toshiyuki
Naito, Yuji
Kanai, Takanori
Suzuki, Yasuo
Nojima, Masanori
Watanabe, Mamoru
Hibi, Toshifumi
GASTROENTEROLOGY, 2017, 152 (05) : S746 - S746
[2] Efficacy of adalimumab for the treatment of TNF-antagonist-naive patients with Crohn's disease: Subanalysis of a phase III trial
Hanauer, Stephen
Sandborn, William
Rutgeerts, Paul
Colombel, Jean Fred
Chao, Jingdong
Mulani, Parvez
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S381 - S382
[3] Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial
Nakase, H.
Motoya, S.
Matsumoto, T.
Watanabe, K.
Hisamatsu, T.
Yoshimura, N.
Ishida, T.
Kato, S.
Nakagawa, T.
Esaki, M.
Nagahori, M.
Matsui, T.
Naito, Y.
Kanai, T.
Suzuki, Y.
Nojima, M.
Watanabe, M.
Hibi, T.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (09) : 873 - 882
[4] Subanalysis of Remission Rates By Duration of Disease in Adalimumab-Treated Patients with Crohn's Disease: the Care Trial
Reinisch, Walter
Lofberg, Robert
Louis, Edouard
Kron, Martina
Camez, Anne
Robinson, Anne
Pollack, Paul F.
GASTROENTEROLOGY, 2009, 136 (05) : A523 - A524
[5] Pharmacokinetics of adalimumab in Crohn’s disease
David Ternant
Konstantinos Karmiris
Severine Vermeire
Céline Desvignes
Nicolas Azzopardi
Theodora Bejan-Angoulvant
Gert van Assche
Gilles Paintaud
European Journal of Clinical Pharmacology, 2015, 71 : 1155 - 1157
[6] Pharmacokinetics of adalimumab in Crohn's disease
Ternant, David
Karmiris, Konstantinos
Vermeire, Severine
Desvignes, Celine
Azzopardi, Nicolas
Bejan-Angoulvant, Theodora
van Assche, Gert
Paintaud, Gilles
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (09) : 1155 - 1157
[7] Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study]
Hisamatsu, Tadakazu
Matsumoto, Takayuki
Watanabe, Kenji
Nakase, Hiroshi
Motoya, Satoshi
Yoshimura, Naoki
Ishida, Tetsuya
Kato, Shingo
Nakagawa, Tomoo
Esaki, Motohiro
Nagahori, Masakazu
Matsui, Toshiyuki
Naito, Yuji
Kanai, Takanori
Suzuki, Yasuo
Nojima, Masanori
Watanabe, Mamoru
Hibi, Toshifumi
Andoh, Akira
Ashida, Toshifumi
Endo, Katsuya
Endo, Yutaka
Esaki, Motohiro
Fujita, Hiroshi
Fujiya, Mikihiro
Haruma, Ken
Hibi, Toshifumi
Hiraoka, Sakiko
Hirata, Ichiro
Hisamatsu, Tadakazu
Honda, Yutaka
Iijima, Hideki
Iizuka, Bunei
Ikeya, Kentaro
Inoue, Takuya
Inoue, Syuji
Ishida, Tetsuya
Ishiguro, Yo
Ishihara, Shunji
Ito, Hiroaki
Iwakiri, Ryuichi
Kagaya, Takashi
Kanai, Takanori
Kashida, Hiroshi
Kato, Shingo
Kato, Jun
Katsurada, Takehiko
Kinjyo, Fukunori
Kobayashi, Kiyonori
Kodama, Mayumi
JOURNAL OF CROHNS & COLITIS, 2019, 13 (09): : 1097 - 1104
[8] Association between serum adalimumab concentrations and endoscopic disease activity in patients with Crohn's disease
Morita, Yukihiro
Imaeda, Hirotsugu
Nishida, Atsushi
Inatomi, Osamu
Bamba, Shigeki
Sasaki, Masaya
Tsujikawa, Tomoyuki
Sugimoto, Mitsushige
Andoh, Akira
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (11) : 1831 - 1836
[9] Induction of Remission with Adalimumab in Patients with Moderate Crohn's Disease: Subanalysis of CLASSIC I
Sandborn, William
Colombel, Jean-Frederic
Castillo, Majin
Zhou, Qian
Thakkar, Roopal
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S436 - S437
[10] INDUCTION OF REMISSION WITH ADALIMUMAB IN PATIENTS WITH MODERATE CROHN'S DISEASE: SUBANALYSIS OF CLASSIC I
Sandborn, W. J.
Colombel, J-F
Castillo, M. M.
Zhou, Q.
Thakkar, R. B.
GUT, 2012, 61 : A228 - A229

← 1 2 3 4 5 →